Bruker mandatory convertible preferred stock offering
The preferred stock will be listed on Nasdaq
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Precigen $125 million financing
We advised Precigen on the loan agreement
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Tempus AI $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
PureCycle Technologies $300 million private placement
We advised the placement agents on the equity offering
ADC Therapeutics $100 million private placement
We advised ADC Therapeutics on the equity offering
Sabre $1.325 billion notes offering and concurrent cash tender offer
We advised Sabre on its high-yield notes offering and on a debt tender offer
Insulet $419 million repurchases of convertible senior notes
We advised the agent on the transaction
Insulet $450 million senior notes offering
The high-yield notes are due 2033
Spirit Airlines emerges from chapter 11
We advised Spirit in connection with its chapter 11 cases